gvtcx

Prosigna Kits

Royal Marsden NHS Foundation Trust Published 13 Jan 2022 Contracts Finder

key details

Value£204,000
Statuscomplete
Category (CPV) 33141620
Deadline19 Dec 2021
Contract start20 Dec 2021
Contract end19 Dec 2023
SME suitableNo
OCIDocds-b5fd17-64390e1d-3249-492a-9500-003e6baf49c8

Award

SupplierValueDateStatus
VERACYTE £204,000 6 Jan 2022 active

description

Breast cancer prognostic tests are genomic tests which are used to determine a woman's risk of hormone receptor breast cancer recurrence as well as how likely she is to benefit from chemotherapy after breast cancer surgery and/or extended endocrine treatm

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
13 Jan 2022 Award (award) · c656f5c5-4834-421e-8ba5-152d93791f52-500226

more from Royal Marsden NHS Foundation Trust

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.